Towards the use of cannabinoids as antitumour agents
Top Cited Papers
- 4 May 2012
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 12 (6) , 436-444
Abstract
Various reports have shown that cannabinoids (the active components of marijuana and their derivatives) can reduce tumour growth and progression in animal models of cancer, in addition to their well-known palliative effects on some cancer-associated symptoms. This Opinion article discusses our current understanding of cannabinoids as antitumour agents, focusing on recent insights into the molecular mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches. Such knowledge is required for the optimization of preclinical cannabinoid-based therapies and for the preliminary clinical testing that is currently underway.Keywords
This publication has 101 references indexed in Scilit:
- Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanismCell Death & Disease, 2011
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagyCell Death & Differentiation, 2011
- Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral actionCell Death & Differentiation, 2011
- Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive propertiesEuropean Journal of Immunology, 2010
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasisBreast Cancer Research and Treatment, 2010
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppressionImmunobiology, 2010
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- Autophagy fights disease through cellular self-digestionNature, 2008
- Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colonJournal of Molecular Medicine, 2007
- CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agentsClinical Immunology, 2007